ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

U.S. Food and Drug Administration Expands Deployment of Waters Corporation Software to Support its Medical Products Testing Labs

News Summary:

  • The U.S. FDA is expanding its use of Waters’ compliant-ready Empower Chromatography Data Software (CDS) and has added NuGenesis Laboratory Management Software (LMS) to support its medical products testing labs.
  • Will provide common data management platform for five U.S. field labs performing pharmaceuticals analysis using a variety of measurement technologies.
  • Transition to electronic records management system will speed data retrieval, automate essential audit and archival functions, and ensure compliance with legislative mandates.

Waters Corporation (NYSE: WAT) today announced the U.S. Food and Drug Administration’s (FDA) Office of Regulatory Affairs (ORA) has purchased Waters™ Empower™ Chromatography Data Software (CDS) and NuGenesis™ Laboratory Management Software (LMS), expanding its deployment of Waters’ software to support its medical products testing operations across its five field science laboratories.

Both Waters software applications will provide the ORA labs a common platform for acquiring, processing, reporting, and archiving analytical data from a variety of measurement instruments. Transitioning to a fully-electronic, common data management strategy will also help ORA’s laboratories realize greater operational efficiencies and bring them closer to compliance with the Paperwork Reduction Act of 1995 and the National Archives and Records Administration stated goals of phasing out paper records beginning in 2022.

“We’re extremely grateful to the FDA for putting its trust in Waters’ Empower and NuGenesis software, expanding the capabilities of its labs to centrally capture, retrieve and secure vital data for nationwide testing of medical products in the United States,” said Dr. Udit Batra, President and CEO, Waters Corporation. “Since we commercialized Empower software 25 years ago, it has become the choice of numerous regulatory agencies and thousands of scientific organizations worldwide. Regulatory agencies like the FDA rely on the integrity and traceability of their lab data to help make vital decisions about the safety, purity and efficacy of drug products to help protect public health.”

In addition to supplying the software, Waters will install the computer hardware, assist with instrument qualification and software validation and train site analysts on the operation, configuration, and expansion of the data management system.

ORA is the lead office for all FDA field activities. Its laboratories inspect drug manufacturers, conduct sample analyses of regulated drug products and review imported pharmaceuticals offered for entry into the United States. The laboratories also perform a variety of chemical and materials analyses including high performance liquid chromatography (HPLC) and UltraPerformance Liquid Chromatography (UPLC™), mass spectrometry, nuclear magnetic resonance (NMR) imaging, spectroscopy, and thermal analysis.

The Waters Empower CDS is the world’s leading chromatography software platform with more than 250,000 licenses in use today. The enterprise version of Empower software controls and collects gas and liquid chromatography data from a variety of instrumentation brands throughout a laboratory and is a platform for assembling, reviewing, approving, and publishing data in various reporting formats. The Waters NuGenesis LMS links many types of laboratory data to the business operations of the enterprise with functionality such as sample submission, results review, stability testing, scientific search, multi-vendor software connection, laboratory inventories, data retention and legal hold, and laboratory execution methods.

Both Waters Empower CDS and NuGenesis LMS are available from Waters separately or as fully integrated software applications.

Additional Resources:

About Waters Corporation (www.waters.com)

Waters Corporation (NYSE: WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, and food sciences for more than 60 years. With more than 7,400 employees worldwide, Waters operates directly in 35 countries, including 14 manufacturing facilities, and with products available in more than 100 countries.

Waters, UPLC, Empower and NuGenesis are trademarks of Waters Corporation.

“We’re extremely grateful to the FDA for putting its trust in Waters’ Empower and NuGenesis software ... " - Dr. Udit Batra, President and CEO, Waters Corporation

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  231.16
+1.49 (0.65%)
AAPL  279.23
+2.26 (0.82%)
AMD  212.42
+6.29 (3.05%)
BAC  53.05
+0.57 (1.09%)
GOOG  319.34
-4.30 (-1.33%)
META  636.37
+0.15 (0.02%)
MSFT  487.05
+10.06 (2.11%)
NVDA  180.21
+2.39 (1.34%)
ORCL  204.85
+7.82 (3.97%)
TSLA  421.46
+2.06 (0.49%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.